Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy.
Lupu
Marilena
M
McCune
Jeannine S
JS
Kuhr
Christian S
CS
Gooley
Theodore
T
Storb
Rainer
R
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000494:pharmacology; D019540:Area Under Curve; D001682:Biological Availability; D004285:Dogs; D004347:Drug Interactions; D004764:Enterohepatic Circulation / Q000187:drug effects; D041981:Gastrointestinal Tract / Q000378:metabolism / Q000382:microbiology; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D007279:Injections, Subcutaneous; D007408:Intestinal Absorption; D008297:Male; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D009355:Neomycin / Q000493:pharmacokinetics / Q000494:pharmacology; D011112:Polymyxin B / Q000493:pharmacokinetics / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D009355:Neomycin; D011112:Polymyxin B